OR WAIT null SECS
© 2022 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
May 11, 2022
Investigators observed higher levels of depression in children and adolescents with ADHD during MPH treatment.
May 10, 2022
Recommendations are often vague, contradictory, according to investigators.
May 05, 2022
Some of the more severe ADHD symptoms noted were depression/withdrawal, problems with socialization.
May 03, 2022
Top-line data for study is expected in late 2022, early 2023.
May 02, 2022
Physical activity, marital status among factors contributing to complete mental health among participants.
Approval comes 1 year after the drug was approved for the treatment of ADHD in children and adolescents.